Synova nets 16.1x on Kinapse sale

The sale of the life sciences outsourcing business to HgCapital follows the successful close of Synova Capital Fund III on its £250m hard-cap.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this